Mednet Logo
HomeQuestion

What is your preferred approach to adjuvant therapy for a Masaoka Stage III thymic carcinoma after R1 resection?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

The data for adjuvant treatment of thymic carcinoma is relatively scarce, with most studies and series on this topic have traditionally included all thymic malignancies including thymomas. In the scenario presented in the question, there are multiple risk factors- thymic carcinoma, R1 resection both...

Register or Sign In to see full answer